{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T04:58:41Z","timestamp":1793336321149,"version":"4.5.0"},"reference-count":92,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","gastrojournal.org","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1053\/j.gastro.2021.08.032","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T02:22:22Z","timestamp":1629426142000},"page":"1865-1877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"161","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3164-8243","authenticated-orcid":false,"given":"Brigida","family":"Barberio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Massimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Cazzagon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Zingone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander C.","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo V.","family":"Savarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2021.08.032_bib1","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European evidence-based consensus on diagnosis and management of ulcerative colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.08.032_bib2","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1093\/ecco-jcc\/jjz180","article-title":"ECCO guidelines on therapeutics in Crohn\u2019s disease: medical treatment","volume":"14","author":"Torres","year":"2020","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"issue":"5","key":"10.1053\/j.gastro.2021.08.032_bib3","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/S2468-1253(21)00014-5","article-title":"Prevalence of anxiety and depression in inflammatory bowel disease: systematic review and meta-analysis","volume":"6","author":"Barberio","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s10620-020-06268-5","article-title":"Inflammatory bowel disease and sleep disturbance: as usual, quality matters","volume":"66","author":"Barberio","year":"2021","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2021.08.032_bib5","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/ajg.2010.343","article-title":"Frequency and risk factors for extraintestinal manifestations in the swiss inflammatory bowel disease cohort","volume":"106","author":"Vavricka","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib6","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1038\/ajg.2015.112","article-title":"ACG clinical guideline: primary sclerosing cholangitis","volume":"110","author":"Lindor","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1080\/00365520600787994","article-title":"Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden","volume":"42","author":"Bergquist","year":"2007","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib8","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.1016\/j.jhep.2008.01.020","article-title":"The challenges in primary sclerosing cholangitis\u2014aetiopathogenesis, autoimmunity, management and malignancy","volume":"48","author":"Weism\u00fcller","year":"2008","journal-title":"J\u00a0Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib9","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1002\/ibd.21219","article-title":"Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease","volume":"16","author":"Navaneethan","year":"2010","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib10","doi-asserted-by":"crossref","first-page":"153","DOI":"10.3109\/00365529709000186","article-title":"Hepatobiliary and coexisting pancreatic duct abnormalities in patients with inflammatory bowel disease","volume":"32","author":"Heikius","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib11","doi-asserted-by":"crossref","first-page":"P178","DOI":"10.1186\/cc12116","article-title":"Indocyanine green plasma disappearance rate for assessment of liver function: re-evaluation of normal ranges and impact of biometric data","volume":"17","author":"Huber","year":"2013","journal-title":"Crit Care"},{"key":"10.1053\/j.gastro.2021.08.032_bib12","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1016\/j.gastro.2003.07.011","article-title":"Incidence, clinical spectrum, and outcomes of primary sclerosing cholangitis in a United States community","volume":"125","author":"Bambha","year":"2003","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.08.032_bib13","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/0002-9610(66)90339-4","article-title":"Primary sclerosing cholangitis. A study of forty-two cases","volume":"111","author":"Warren","year":"1966","journal-title":"Am J Surg"},{"key":"10.1053\/j.gastro.2021.08.032_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/apt.12794","article-title":"Systematic review: the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease","volume":"40","author":"Gizard","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.08.032_bib15","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"Br Med J"},{"issue":"Suppl A","key":"10.1053\/j.gastro.2021.08.032_bib16","doi-asserted-by":"crossref","first-page":"5A","DOI":"10.1155\/2005\/269076","article-title":"Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a working party of the 2005 Montreal World Congress of Gastroenterology","volume":"19","author":"Silverberg","year":"2005","journal-title":"Can J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"Br Med J"},{"key":"10.1053\/j.gastro.2021.08.032_bib18","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2021.08.032_bib19","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/0002-9610(80)90239-1","article-title":"Hepatobiliary complications of ulcerative colitis","volume":"139","author":"Lupinetti","year":"1980","journal-title":"Am J Surg"},{"key":"10.1053\/j.gastro.2021.08.032_bib20","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3109\/00365528209181041","article-title":"Sclerosing cholangitis in ulcerative colitis: a follow-up study","volume":"17","author":"Schrumpf","year":"1982","journal-title":"Scand J Gastroenterol"},{"issue":"208","key":"10.1053\/j.gastro.2021.08.032_bib21","first-page":"503","article-title":"Ulcerative colitis and persistent liver dysfunction","volume":"52","author":"Shepherd","year":"1983","journal-title":"Q\u00a0J Med"},{"issue":"7","key":"10.1053\/j.gastro.2021.08.032_bib22","first-page":"229","article-title":"Primary sclerosing cholangitis associated with inflammatory bowel disease in Cape Town, 1975\u20131981","volume":"63","author":"Tobias","year":"1983","journal-title":"S\u00a0Afr Med J"},{"key":"10.1053\/j.gastro.2021.08.032_bib23","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1016\/0016-5085(91)70019-T","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis","volume":"100","author":"Olsson","year":"1991","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.08.032_bib24","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/00365529108996489","article-title":"Prevalence of hepatobiliary dysfunction in a regional group of patients with chronic inflammatory bowel disease","volume":"26","author":"Wewer","year":"1991","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib25","doi-asserted-by":"crossref","first-page":"732","DOI":"10.3109\/00365529209011174","article-title":"Primary sclerosing cholangitis in patients with ulcerative colitis","volume":"27","author":"Rasmussen","year":"1992","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib26","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1440-1746.1993.tb01506.x","article-title":"Prevalence of primary sclerosing cholangitis and other liver diseases in Japanese patients with chronic ulcerative colitis","volume":"8","author":"Hashimoto","year":"1993","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"4","key":"10.1053\/j.gastro.2021.08.032_bib27","first-page":"275","article-title":"Prevalence of hepatobiliary dysfunction in patients with ulcerative colitis","volume":"83","author":"Aitola","year":"1994","journal-title":"Ann Chir Gynaecol"},{"key":"10.1053\/j.gastro.2021.08.032_bib28","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1136\/gut.35.1.84","article-title":"Liver disease in ulcerative colitis: an epidemiological and follow up study in the county of Stockholm","volume":"35","author":"Broom\u00e9","year":"1994","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.08.032_bib29","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/00004836-199607000-00009","article-title":"Immune-related systemic manifestations of inflammatory bowel disease: a prospective study of 792 patients","volume":"23","author":"Veloso","year":"1996","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib30","doi-asserted-by":"crossref","first-page":"604","DOI":"10.3109\/00365529709025107","article-title":"Hepatobiliary dysfunction and primary sclerosing cholangitis in patients with Crohn\u2019s disease","volume":"32","author":"Rasmussen","year":"1997","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib31","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1007\/BF02234596","article-title":"Flow cytometric and histologic evaluation in a large cohort of patients with ulcerative colitis: correlation with clinical characteristics and impact on surveillance","volume":"44","author":"Holzmann","year":"2001","journal-title":"Dis Colon Rectum"},{"key":"10.1053\/j.gastro.2021.08.032_bib32","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/00004836-200110000-00008","article-title":"Primary sclerosing cholangitis in patients with inflammatory bowel disease in Turkey","volume":"33","author":"Parlak","year":"2001","journal-title":"J\u00a0Clin Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib33","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.3748\/wjg.v9.i10.2300","article-title":"Association of extraintestinal manifestations of inflammatory bowel\u00a0disease in a province of western Hungary with disease phenotype: results of a 25-year follow-up study","volume":"9","author":"Lakatos","year":"2003","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib34","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1007\/s00384-004-0598-0","article-title":"Sonographic detection of perihepatic lymphadenopathy is an indicator for primary sclerosing cholangitis in patients with inflammatory bowel disease","volume":"19","author":"Hirche","year":"2004","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib35","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1111\/j.1440-1746.2005.03905.x","article-title":"Inflammatory bowel disease in Iran: a review of 457 cases","volume":"20","author":"Aghazadeh","year":"2005","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1157\/13078423","article-title":"Manifestaciones extraintestinales en la enfermedad inflamatoria intestinal: diferencias entre la enfermedad de Crohn y la colitis ulcerosa","volume":"125","author":"Mendoza","year":"2005","journal-title":"Med Clin (Barc)"},{"key":"10.1053\/j.gastro.2021.08.032_bib37","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1097\/01.meg.0000243883.47938.aa","article-title":"Relationship between clinical features of Crohn\u2019s disease and the risk of developing extraintestinal manifestations","volume":"19","author":"Barreiro\u2013de Acosta","year":"2007","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib38","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/j.1572-0241.2006.00947.x","article-title":"Abnormal hepatic biochemistries in patients with inflammatory bowel disease","volume":"102","author":"Mendes","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib39","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ibd.20529","article-title":"Prevalence of penetrating disease and extraintestinal manifestations of Crohn\u2019s disease detected with CT enterography","volume":"14","author":"Bruining","year":"2008","journal-title":"Inflamm Bowel Dis"},{"issue":"1","key":"10.1053\/j.gastro.2021.08.032_bib40","first-page":"26","article-title":"Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis and the risk of developing malignancies. A large prospective study","volume":"38","author":"Terg","year":"2008","journal-title":"Acta Gastroenterol Latinoam"},{"issue":"5","key":"10.1053\/j.gastro.2021.08.032_bib41","first-page":"454","article-title":"Epidemiologic characteristics of 500 patients with inflammatory bowel disease in Iran studied from 2004 through 2007","volume":"12","author":"Vahedi","year":"2009","journal-title":"Arch Iran Med"},{"key":"10.1053\/j.gastro.2021.08.032_bib42","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/S1665-2681(19)31615-1","article-title":"Prevalence and factors associated with the presence of abnormal function liver tests in patients with ulcerative colitis","volume":"9","author":"Yamamoto-Furusho","year":"2010","journal-title":"Ann Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib43","doi-asserted-by":"crossref","first-page":"A138","DOI":"10.1136\/gut.2011.239301.294","article-title":"The prevalence of abnormal hepatic biochemistry and hepatobiliary morbidity in a cohort of patients with inflammatory bowel disease","volume":"60","author":"Davies","year":"2011","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.08.032_bib44","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ibd.21569","article-title":"Clinical characteristics of ulcerative colitis associated with primary sclerosing cholangitis in Korea","volume":"17","author":"Ye","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib45","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.jcma.2012.02.017","article-title":"Long-term follow-up of ulcerative colitis in Taiwan","volume":"75","author":"Wei","year":"2012","journal-title":"J\u00a0Chin Med Assoc"},{"key":"10.1053\/j.gastro.2021.08.032_bib46","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.1016\/S1590-8658(13)60608-8","article-title":"Primary sclerosing cholangitis in inflammatory bowel diseases: experience of a single Italian centre","volume":"45","author":"Andreoli","year":"2013","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib47","doi-asserted-by":"crossref","first-page":"300","DOI":"10.3109\/00365521.2014.991752","article-title":"Extraintestinal manifestations in Crohn\u2019s disease and ulcerative colitis: results from a prospective, population-based European inception cohort","volume":"50","author":"Isene","year":"2014","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib48","doi-asserted-by":"crossref","first-page":"12269","DOI":"10.3748\/wjg.v20.i34.12269","article-title":"Smoking increases the risk of extraintestinal manifestations in Crohn\u2019s disease","volume":"20","author":"Ott","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib49","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1159\/000363228","article-title":"Extraintestinal manifestations of inflammatory bowel disease and the influence of smoking","volume":"90","author":"Roberts","year":"2014","journal-title":"Digestion"},{"key":"10.1053\/j.gastro.2021.08.032_bib50","doi-asserted-by":"crossref","first-page":"17463","DOI":"10.3748\/wjg.v20.i46.17463","article-title":"Extraintestinal manifestations in a large series of Italian inflammatory bowel disease patients","volume":"20","author":"Zippi","year":"2014","journal-title":"World J Gastroenterol"},{"issue":"4Suppl1","key":"10.1053\/j.gastro.2021.08.032_bib51","doi-asserted-by":"crossref","first-page":"S455","DOI":"10.1016\/S0016-5085(15)31535-3","article-title":"Prevalence, causes and impact of abnormal liver biochemistries in patients with inflammatory bowel disease","volume":"148","author":"Bonnivard","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.08.032_bib52","first-page":"200","article-title":"Frequency and risk factors of primary sclerosing cholangitis among patients with inflammatory bowel disease in north-east of Iran","volume":"8","author":"Khorashad","year":"2015","journal-title":"Gastroenterol Hepatol Bed Bench"},{"issue":"5 Suppl 1","key":"10.1053\/j.gastro.2021.08.032_bib53","first-page":"A332","article-title":"Liver injury in treated inflammatory bowel disease patients: prevalence, severity, evolution and implications for further\u00a0treatment","volume":"3","author":"Koller","year":"2015","journal-title":"United European Gastroenterol J"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.08.032_bib54","doi-asserted-by":"crossref","first-page":"S830","DOI":"10.14309\/00000434-201510001-01963","article-title":"Successful management of extra-intestinal manifestations of inflammatory bowel disease","volume":"110","author":"Martinez","year":"2015","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib55","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1111\/jgh.12947","article-title":"Appearance of hepatobiliary diseases in a population-based cohort with inflammatory bowel diseases (Inflammatory Bowel Disease Cohort of the Uppsala Region)","volume":"30","author":"R\u00f6nnblom","year":"2015","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib56","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s12664-015-0538-7","article-title":"Extraintestinal manifestations of inflammatory bowel disease and intestinal tuberculosis: frequency and relation with disease phenotype","volume":"34","author":"Singh","year":"2015","journal-title":"Indian J Gastroenterol"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.08.032_bib57","doi-asserted-by":"crossref","first-page":"S289","DOI":"10.14309\/00000434-201610001-00629","article-title":"Ulcerative colitis with PSC have higher mortality, higher healthcare utilization, and worse clinical outcomes compared to UC only patients: National inpatient sample","volume":"111","author":"Bhardwaj","year":"2016","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib58","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/MEG.0000000000000747","article-title":"Primary sclerosing cholangitis in the Swiss Inflammatory Bowel Disease Cohort Study: prevalence, risk factors, and long-term follow-up","volume":"29","author":"Fraga","year":"2017","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib59","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1093\/ecco-jcc\/jjv232","article-title":"Prevalence and characteristics of extra-intestinal manifestations in a large cohort of Greek patients with inflammatory bowel disease","volume":"10","author":"Karmiris","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.08.032_bib60","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/MIB.0000000000000587","article-title":"Multiyear patterns of serum inflammatory biomarkers and risk of colorectal neoplasia in patients with ulcerative colitis","volume":"22","author":"Koutroubakis","year":"2016","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib61","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1053\/j.gastro.2016.06.021","article-title":"Prevalence of sclerosing cholangitis detected by magnetic resonance cholangiography in patients with long-term inflammatory bowel disease","volume":"151","author":"Lunder","year":"2016","journal-title":"Gastroenterology"},{"issue":"S9","key":"10.1053\/j.gastro.2021.08.032_bib62","article-title":"Epidemiology of primary sclerosing cholangitis in inflammatory bowel disease: a longitudinal saudi cohort study","volume":"23","author":"Azzam","year":"2017","journal-title":"Saudi J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib63","doi-asserted-by":"crossref","first-page":"6137","DOI":"10.3748\/wjg.v23.i33.6137","article-title":"Patients with inflammatory bowel disease have increased risk of autoimmune and inflammatory diseases","volume":"23","author":"Halling","year":"2017","journal-title":"World J Gastroenterol"},{"issue":"Suppl 4","key":"10.1053\/j.gastro.2021.08.032_bib64","first-page":"88","article-title":"Characteristics of extraintestinal manifestations (EIM) in a local cohort of patients with inflammatory bowel disease (IBD)","volume":"33","author":"Lin","year":"2018","journal-title":"J\u00a0Gastroenterol Hepatol"},{"issue":"8 Suppl","key":"10.1053\/j.gastro.2021.08.032_bib65","first-page":"A150","article-title":"Prevalence of hepato-biliary manifestation in IBD","volume":"6","author":"Osmane","year":"2018","journal-title":"United European Gastroenterol J"},{"key":"10.1053\/j.gastro.2021.08.032_bib66","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.1093\/ecco-jcc\/jjx180.945","article-title":"Prevalence and risk factors of comorbid immune-mediated diseases in patients with inflammatory bowel disease: a nationwide population-based study in South Korea","author":"Park","year":"2018","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.08.032_bib67","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/ecco-jcc\/jjy061","article-title":"Phenotype and clinical course of inflammatory bowel disease with co-existent celiac disease","volume":"12","author":"Tse","year":"2018","journal-title":"J\u00a0Crohn\u2019s Colitis"},{"issue":"2","key":"10.1053\/j.gastro.2021.08.032_bib68","doi-asserted-by":"crossref","first-page":"139","DOI":"10.5152\/tjg.2018.18221","article-title":"Colorectal cancer and dysplasia risk of ulcerative colitis patients in a tertiary referral center in Turkey","volume":"30","author":"\u00dcnal","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib69","article-title":"Prevalence of extraintestinal manifestations in Korean inflammatory bowel disease patients","volume":"13","author":"Yang","year":"2018","journal-title":"PLoS One"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.08.032_bib70","doi-asserted-by":"crossref","first-page":"S1323","DOI":"10.1016\/S0016-5085(19)40325-9","article-title":"The association between primary biliary cholangitis and ulcerative colitis: large inpatient database study","volume":"156","author":"Alsuleiman","year":"2019","journal-title":"Gastroenterology"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2021.08.032_bib71","first-page":"S514","article-title":"Hepatobiliary manifestations associated to chronic inflammatory bowel disease","volume":"30","author":"Cheikhna","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s12876-019-0967-3","article-title":"Hepatobiliary and pancreatic manifestations in inflammatory bowel diseases: a referral center study","volume":"19","author":"Fousekis","year":"2019","journal-title":"BMC Gastroenterol"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2021.08.032_bib73","first-page":"S535","article-title":"Profile of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"30","author":"Gharbi","year":"2019","journal-title":"Tur J Gastroenterol"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2021.08.032_bib74","first-page":"S322","article-title":"Liver involvement in inflammatory bowel disease-retrospective data from a tertiary center in north-eastern Romania","volume":"30","author":"GlicA-Blanariu","year":"2019","journal-title":"Turk J Gastroenterol"},{"issue":"Suppl 3","key":"10.1053\/j.gastro.2021.08.032_bib75","first-page":"S662","article-title":"Hepatobiliary involvement in patients with inflammatory bowel disease","volume":"30","author":"Nasrullayeva","year":"2019","journal-title":"Turk J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib76","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1007\/s10620-020-06424-x","article-title":"Extraintestinal manifestations in patients with inflammatory bowel disease: study based on the ENEIDA Registry","volume":"66","author":"Algaba","year":"2021","journal-title":"Dig Dis Sci"},{"issue":"Suppl 1","key":"10.1053\/j.gastro.2021.08.032_bib77","first-page":"S37","article-title":"Study of profile of hepatic disorders in patients with inflammatory bowel disease: our experience in tertiary care hospital","volume":"39","author":"Dixit","year":"2020","journal-title":"Indian J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib78","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.gastrohep.2020.07.012","article-title":"Characterization and prevalence of extraintestinal manifestations in a cohort of patients with inflammatory intestinal disease in Medellin, Colombia","volume":"44","author":"Juliao-Ba\u00f1os","year":"2021","journal-title":"Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib79","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.dld.2020.06.046","article-title":"Extraintestinal manifestation of inflammatory bowel disease in Asian patients: a multinational study","volume":"53","author":"Park","year":"2021","journal-title":"Dig Liver Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib80","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1053\/j.gastro.2020.05.049","article-title":"Effects of primary sclerosing cholangitis on risks of cancer and death in people with inflammatory bowel disease, based on sex, race, and age","volume":"159","author":"Trivedi","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2021.08.032_bib81","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/0002-9343(94)90173-2","article-title":"Age and sex associations of 40 autoimmune diseases","volume":"96","author":"Beeson","year":"1994","journal-title":"Am J Med"},{"key":"10.1053\/j.gastro.2021.08.032_bib82","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1111\/eva.13167","article-title":"Why women have more autoimmune diseases than men: an evolutionary perspective","volume":"14","author":"Kronzer","year":"2021","journal-title":"Evol Appl"},{"key":"10.1053\/j.gastro.2021.08.032_bib83","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1007\/s00534-010-0319-8","article-title":"Clinical characteristics of inflammatory bowel disease associated with primary sclerosing cholangitis","volume":"18","author":"Sano","year":"2011","journal-title":"J\u00a0Hepatobil Pancreat Sci"},{"key":"10.1053\/j.gastro.2021.08.032_bib84","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1002\/ibd.21699","article-title":"Inflammatory bowel disease in patients with primary sclerosing cholangitis: clinical characterization in liver transplanted and nontransplanted patients","volume":"18","author":"J\u00f8rgensen","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2021.08.032_bib85","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.3748\/wjg.v21.i6.1956","article-title":"Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis","volume":"21","author":"Vries","year":"2015","journal-title":"World J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib86","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.crohns.2011.07.015","article-title":"A\u00a0unique clinical phenotype of primary sclerosing cholangitis associated with Crohn\u2019s disease","volume":"6","author":"Halliday","year":"2012","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2021.08.032_bib87","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00365528709011139","article-title":"Primary sclerosing cholangitis: a long-term follow-up study","volume":"22","author":"Aadland","year":"1987","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2021.08.032_bib88","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.cgh.2012.12.032","article-title":"Association between reduced levels of alkaline phosphatase and survival times of patients with primary sclerosing cholangitis","volume":"11","author":"Lindstr\u00f6m","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2021.08.032_bib89","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1136\/gut.38.4.610","article-title":"Natural history and prognostic factors in 305 Swedish patients with primary sclerosing cholangitis","volume":"38","author":"Broom\u00e9","year":"1996","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2021.08.032_bib90","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/j.1365-2036.2011.04753.x","article-title":"Review article: Colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease","volume":"34","author":"Torres","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2021.08.032_bib91","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1572-0241.2004.04067.x","article-title":"Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis","volume":"99","author":"Burak","year":"2004","journal-title":"Am J Gastroenterol"},{"issue":"6","key":"10.1053\/j.gastro.2021.08.032_bib92","doi-asserted-by":"crossref","first-page":"659","DOI":"10.3748\/wjg.v25.i6.659","article-title":"Cancer risk in primary sclerosing cholangitis: epidemiology, prevention, and surveillance strategies","volume":"25","author":"Fung","year":"2019","journal-title":"World J Gastroenterol"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521034120?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508521034120?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,3,6]],"date-time":"2024-03-06T22:46:59Z","timestamp":1709765219000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508521034120"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,12]]},"references-count":92,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S0016508521034120"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2021.08.032","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of Primary Sclerosing Cholangitis in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2021.08.032","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute","name":"copyright","label":"Copyright"}]}}